CDAD In recent years, CDAD has gained increasing attention as a potential PPI-induced gastrointestinal complication
The NHS advises no more than 14 units per week, spread over three or more days, with several alcohol-free days
Kaur N, Kumari A, Agarwal A, Sabharwal M, Dipti S (2022) Utilisation of Diospyros kaki L
Standard of Care) study for alogliptin (58, 62), the Savor-TIMI-53 study (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes MellitusThrombolysis in Myocardial Infarction 53) for saxagliptin (60, 63), the TECOS study (Trial Evaluating Cardiovascular Outcomes With Sitagliptin) for sitagliptin (59, 64) and the CARMELINA study (Cardiovascular safety and Clinical Outcome with Linagliptin) for linagliptin (61, 65)
While GLP-1 injections are generally well-tolerated, they can cause side effects in some users
In two ethnically Irish populations, one of young adults and another of adults 60, two different polymorphisms were found to increase MMA levels